| Literature DB >> 54578 |
G Jennings, M S Jones, E M Besterman, D G Model, P P Turner, P H Kidner.
Abstract
Oral disopyramide given prophylactically following myocardial infarction has been compared with placebo in a double-blind trial using continuous-tape monoriting of the electocardiogram. It caused a significant reduction in the incidence of ventricular arrhythmias and of the various degrees of heart-block. There was a significant reduction of reinfarction during hospital stay in patients who had received disopyramide. Disopyramide appears to be a safe and effective oral therapy in the prevention of potentially serious arrhythmias following myocardial infarction.Entities:
Mesh：
Substances：
Year: 1976 PMID： 54578 DOI： 10.1016/s0140-6736(76)90148-3
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321